The endangered physician-scientist and COVID-19
- PMID: 33521693
- PMCID: PMC7832285
- DOI: 10.1016/j.xcrm.2021.100190
The endangered physician-scientist and COVID-19
Abstract
The COVID-19 pandemic has affected almost every stakeholder in healthcare, including the vulnerable population of clinician investigators known as physician-scientists. In this commentary, Rao et al. highlight the underappreciated challenges and opportunities, and present solutions, for physician-scientists vis-à-vis the uniquely disruptive event of the pandemic.
© 2021 The Author(s).
Conflict of interest statement
No funding source influenced or reviewed the contents and/or conclusions of this work. No commercial relationship exists for any author.
References
-
- Dzau V.J., Cho A., Ellaissi W., Yoediono Z., Sangvai D., Shah B., Zaas D., Udayakumar K. Transforming academic health centers for an uncertain future. N. Engl. J. Med. 2013;369:991–993. - PubMed
-
- Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C.L. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 2001;344:1031–1037. - PubMed
-
- Corey L., Mascola J.R., Fauci A.S., Collins F.S. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948–950. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
